Physician profile
Jose Z De Ocampo
NPI 1255318788
$45,808.89
in general payments reported to CMS, 2019-2025
87 companies · $4,114 in 2025
The $4,114 reported for 2025 was more than what 87% of Sleep Medicine (Psychiatry & Neurology) providers received nationally (typical 2025 total: $337).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,260 · 2020: $13K · 2021: $8,855 · 2022: $4,328 · 2023: $6,151 · 2024: $4,942 · 2025: $4,114.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $14K · Travel and Lodging: $1,055 · Education: $463.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13,689.20 |
| Travel and Lodging | $1,055.08 |
| Education | $462.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $11,352.97 | 2019-2022 | |
| Abbvie INC. | $7,469.49 | 2021-2025 | Ubrelvy, Botox, Qulipta |
| Ucb, INC. | $1,973.57 | 2019-2025 | Briviact, Nayzilam, Fintepla |
| Zoll Respicardia, INC. | $1,756.14 | 2023 | Remede System |
| Jazz Pharmaceuticals INC. | $1,722.35 | 2019-2025 | |
| Alexion Pharmaceuticals, INC. | $1,134.28 | 2019-2025 | Ultomiris |
| Medtronic USA, INC. | $1,107.34 | 2019-2020 | |
| Biogen, INC. | $1,017.39 | 2019-2025 | Vumerity, Tysabri, Spinraza |
| Novartis Pharmaceuticals Corporation | $1,002.22 | 2019-2025 | |
| Eisai INC. | $963.06 | 2019-2025 | |
| Amneal Pharmaceuticals LLC | $945.53 | 2019-2025 | Rytary, Crexont |
| Harmony Biosciences LLC | $903.50 | 2020-2025 | Wakix |
| Sk Life Science, INC. | $786.05 | 2020-2025 | |
| Pfizer INC. | $754.66 | 2021-2025 | |
| Emd Serono, INC. | $674.73 | 2019-2025 | Mavenclad, Mavenclad |
Show all 87 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $636.63 | 2020-2025 | Acthar |
| Genzyme Corporation | $605.90 | 2019-2024 | |
| Genentech USA, INC. | $594.09 | 2019-2025 | Ocrevus, Enspryng, Ocrevus Zunovo |
| Lilly USA, LLC | $593.73 | 2019-2025 | Kisunla, Amyvid, Emgality |
| Amgen INC. | $515.27 | 2019-2025 | |
| Teva Pharmaceuticals USA, INC. | $505.70 | 2019-2023 | Austedo Xr, Austedo |
| Upsher-Smith Laboratories LLC | $487.20 | 2019-2023 | |
| Lundbeck LLC | $477.70 | 2020-2025 | Vyepti, Rexulti |
| Argenx US, INC. | $462.54 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
| Arbor Pharmaceuticals, INC. | $401.33 | 2019-2022 | |
| Axsome Therapeutics, INC. | $394.59 | 2024-2025 | Sunosi |
| Neurocrine Biosciences, INC. | $305.77 | 2019-2025 | Ingrezza |
| Inspire Medical Systems, INC. | $302.23 | 2024 | Inspire |
| Tg Therapeutics, INC. | $284.00 | 2024-2025 | |
| Abbott Laboratories | $258.53 | 2019-2025 | Proclaim, Eterna, Infinity |
| Avadel Cns Pharmaceuticals, LLC | $257.24 | 2023-2025 | Lumryz |
| Biohaven Pharmaceutical Holding Company Ltd. | $248.34 | 2022 | |
| Idorsia Pharmaceuticals US INC | $235.38 | 2022-2024 | Quviviq |
| Avion Pharmaceuticals | $228.96 | 2022-2023 | Dhivy |
| Neurelis, INC. | $223.48 | 2020-2025 | Valtoco |
| Celgene Corporation | $207.49 | 2024-2025 | Zeposia |
| Mdd US Operations, LLC | $205.64 | 2019-2025 | Apokyn, Apokyn, Gocovri |
| Merz Pharmaceuticals, LLC | $200.97 | 2021-2024 | Xeomin |
| Biohaven Pharmaceuticals, INC. | $178.55 | 2021 | |
| Merck Sharp & Dohme LLC | $173.55 | 2020-2023 | Belsomra |
| Xeris Pharmaceuticals, INC. | $157.90 | 2021-2024 | Keveyis |
| Takeda Pharmaceuticals U.S.A., INC. | $156.96 | 2023-2025 | Hyqvia |
| Zyla Life Sciences, INC. | $145.70 | 2019-2020 | |
| Bausch Health US, LLC | $142.64 | 2019-2020 | |
| Csl Behring | $142.24 | 2022-2024 | Hizentra |
| Ipsen Biopharmaceuticals, INC | $132.45 | 2019-2023 | Dysport |
| Boston Scientific Corporation | $126.35 | 2019 | |
| Mallinckrodt Enterprises LLC | $122.20 | 2019 | |
| Tanabe Pharma America, INC. | $121.39 | 2019-2024 | |
| Impel Pharmaceuticals INC. | $119.97 | 2022-2023 | Trudhesa |
| Grt US Holding, INC. | $119.89 | 2019-2021 | |
| Vanda Pharmaceuticals INC. | $115.14 | 2025 | Ponvory |
| Sumitomo Pharma America, INC. | $108.25 | 2023-2024 | Aptiom |
| Avanir Pharmaceuticals, INC. | $106.04 | 2019-2022 | |
| Acadia Pharmaceuticals INC | $103.04 | 2019-2022 | |
| Otsuka America Pharmaceutical, INC. | $101.92 | 2023-2025 | Nuedexta, Rexulti |
| Merz North America, INC. | $95.69 | 2019-2020 | |
| Kyowa Kirin, INC. | $91.10 | 2020-2021 | |
| Acorda Therapeutics, INC | $75.99 | 2022-2023 | Inbrija, Ampyra |
| Grifols USA, LLC | $70.10 | 2019-2025 | Gamunex-C |
| Horizon Therapeutics Plc | $65.80 | 2021-2023 | Uplizna |
| Livanova USA, INC. | $64.94 | 2019-2024 | Vns Therapy Sentiva Model 1000 Generator |
| Assertio Therapeutics, INC. | $61.35 | 2019-2020 | |
| Otto Bock Healthcare Lp | $59.05 | 2020-2023 | |
| Averitas Pharma INC. | $56.88 | 2024-2025 | Qutenza |
| Cycle Pharmaceuticals INC | $50.42 | 2024-2025 | Bafiertam, Tascenso Odt, Ormalvi |
| Astrazeneca Pharmaceuticals Lp | $50.42 | 2025 | Wainua |
| Azurity Pharmaceuticals, INC. | $47.34 | 2023 | Horizant |
| Sunovion Pharmaceuticals INC. | $46.80 | 2021-2022 | |
| Philips North America LLC | $46.25 | 2022-2024 | (6299) Dreamwear |
| E.R. Squibb & Sons, L.L.C. | $35.78 | 2020-2021 | |
| Collegium Pharmaceutical, INC. | $33.56 | 2022 | |
| Supernus Pharmaceuticals, INC. | $33.07 | 2019-2022 | |
| Promius Pharma LLC | $28.74 | 2019 | |
| Currax Pharmaceuticals LLC | $28.61 | 2020-2024 | Onzetra Xsail |
| Alnylam Pharmaceuticals INC. | $25.43 | 2019 | |
| Corium, LLC | $23.49 | 2022 | |
| Strongbridge US INC. | $19.64 | 2020 | |
| Sanofi-Aventis U.S. LLC | $18.76 | 2021 | |
| Globus Medical, INC. | $16.71 | 2025 | Senza |
| Almatica Pharma LLC | $15.83 | 2021 | |
| Banner Life Sciences, LLC | $14.97 | 2023 | |
| Biodelivery Sciences International, INC. | $13.62 | 2021 | |
| Itamar Medical INC | $13.25 | 2024 | Watchpatone |
| Vertical Pharmaceuticals, LLC | $12.45 | 2019 | |
| Chiesi USA, INC. | $11.86 | 2020 | |
| 3b Medical, INC. | $10.82 | 2025 | Luna |
Drugs and devices associated with these payments
Remede System $1,756Botox $872Qulipta $849Briviact $797Ultomiris $732Ubrelvy $726Leqembi $668Nurtec Odt $533Wakix $495Kesimpta $436Sunosi $395Zavzpret $384Xywav $327Inspire $302Briumvi $284Ocrevus $273Lumryz $257Vyvgart Hytrulo $253Vyepti $240Nayzilam $228Rexulti $216Quviviq $215Vumerity $210Zeposia $207Mavenclad $198Xyrem $198Kisunla $181Rytary $177Acthar $151Hyqvia $137Enspryng $121Epidiolex $118Ponvory $115Apokyn $115Dhivy $113Aptiom $108Ingrezza $104Vyvgart $103Ocrevus Zunovo $102Xeomin $100Panzyga $96.90Trudhesa $95.66Amyvid $89.81Proclaim $84.18Tysabri $73.13Crexont $72.48Keveyis $69.49Eterna $67.66Nuedexta $58.89Reyvow $58.65Emgality $58.65Fintepla $57.64Qutenza $56.88Zepbound $55.10Belsomra $50.57Gamunex-C $48.53Gocovri $48.01Horizant $47.34Austedo Xr $43.88Bafiertam $41.99Spinraza $41.78Valtoco $41.55Rystiggo $41.34Octagam Immune Globulin (Human) $37.68Austedo $36.98Hizentra $34.67Inbrija $33.17Dysport $32.36Tascenso Odt $27.02(6299) Dreamwear $26.50Wainua $25.81Ormalvi $23.40Infinity $20.72Vns Therapy Sentiva Model 1000 Generator $20.12Zembrace Symtouch $18.60Uplizna $18.16Senza $16.71Vyalev $16.59Onzetra Xsail $16.51Radicava $15.02Radicava Ors $15.02Watchpatone $13.25Ampyra $12.84Luna $10.82
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jose De Ocampo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.